125 related articles for article (PubMed ID: 3261053)
21. [Serologic hepatitis B markers in porphyria cutanea tarda (author's transl)].
Uthemann H; Kotitschke R; Lissner R; Goerz G
Dtsch Med Wochenschr; 1980 Dec; 105(49):1718-20. PubMed ID: 6777137
[TBL] [Abstract][Full Text] [Related]
22. Co-inheritance of mutations in the uroporphyrinogen decarboxylase and hemochromatosis genes accelerates the onset of porphyria cutanea tarda.
Brady JJ; Jackson HA; Roberts AG; Morgan RR; Whatley SD; Rowlands GL; Darby C; Shudell E; Watson R; Paiker J; Worwood MW; Elder GH
J Invest Dermatol; 2000 Nov; 115(5):868-74. PubMed ID: 11069625
[TBL] [Abstract][Full Text] [Related]
23. Association of porphyria cutanea tarda with hereditary hemochromatosis.
Mehrany K; Drage LA; Brandhagen DJ; Pittelkow MR
J Am Acad Dermatol; 2004 Aug; 51(2):205-11. PubMed ID: 15280838
[TBL] [Abstract][Full Text] [Related]
24. Porphyria cutanea tarda and haemochromatosis: a family study.
Seymour DG; Elder GH; Fryer A; Jacobs A; Williams GT
Gut; 1990 Jun; 31(6):719-21. PubMed ID: 2379879
[TBL] [Abstract][Full Text] [Related]
25. [Association of idiopathic hemochromatosis and tardive cutaneous porphyria].
Buysschaert M; Verstraeten L; Novik V; Brasseur A; Donckier J; Hassoun A
Acta Clin Belg; 1991; 46(5):333-7. PubMed ID: 1661554
[TBL] [Abstract][Full Text] [Related]
26. Familial and sporadic porphyria cutanea tarda: clinical, biochemical and genetic features with emphasis on iron status.
Bygum A; Christiansen L; Petersen NE; Hørder M; Thomsen K; Brandrup F
Acta Derm Venereol; 2003; 83(2):115-20. PubMed ID: 12735639
[TBL] [Abstract][Full Text] [Related]
27. [HLA antigen distribution and porphyria cutanea tarda--a contribution on the problem of the association of HLA with metabolic diseases].
Gebhardt B; Köstler E; Seebacher C
Dermatol Monatsschr; 1984; 170(8):506-10. PubMed ID: 6479408
[No Abstract] [Full Text] [Related]
28. [Immunopathology of porphyria cutanea tarda].
Bidrat MS
Vestn Dermatol Venerol; 1982 Jul; (7):19-23. PubMed ID: 7136251
[No Abstract] [Full Text] [Related]
29. Mechanisms of phototoxicity in porphyria cutanea tarda and erythropoietic protoporphyria.
Lim HW
Immunol Ser; 1989; 46():671-85. PubMed ID: 2488874
[TBL] [Abstract][Full Text] [Related]
30. Mutations of the hereditary hemochromatosis candidate gene HLA-H in porphyria cutanea tarda.
Santos M; Clevers HC; Marx JJ
N Engl J Med; 1997 May; 336(18):1327-8. PubMed ID: 9132598
[No Abstract] [Full Text] [Related]
31. [Significance and prevalence of the C282Y gene mutation of primary hemochromatosis in the pathogenesis of pophyria cutanea tarda].
Malina L; Zd'árský E; Dandová S; Michalíková H; Cerná M; Cimburová M
Cas Lek Cesk; 2000 Nov; 139(23):728-30. PubMed ID: 11191743
[TBL] [Abstract][Full Text] [Related]
32. Decreased hepatic uroporphyrinogen decarboxylase activity in porphyria cutanea tarda.
Felsher BF; Carpio NM; Engleking DW; Nunn AT
N Engl J Med; 1982 Apr; 306(13):766-9. PubMed ID: 7062951
[TBL] [Abstract][Full Text] [Related]
33. The C282Y mutation in the haemochromatosis gene (HFE) and hepatitis C virus infection are independent cofactors for porphyria cutanea tarda in Australian patients.
Stuart KA; Busfield F; Jazwinska EC; Gibson P; Butterworth LA; Cooksley WG; Powell LW; Crawford DH
J Hepatol; 1998 Mar; 28(3):404-9. PubMed ID: 9551677
[TBL] [Abstract][Full Text] [Related]
34. ACQUIRED PORPHYRIA CUTANEA TARDA: REPORT OF A CASE SUCCESSFULLY TREATED BY PHLEBOTOMY.
KOVAL A; DANBY CW; PETERMANN H
Can Med Assoc J; 1965 Sep; 93(10):537-40. PubMed ID: 14341652
[TBL] [Abstract][Full Text] [Related]
35. Immunoreactive uroporphyrinogen decarboxylase in the liver in porphyria cutanea tarda.
Elder GH; Urquhart AJ; De Salamanca RE; Munoz JJ; Bonkovsky HL
Lancet; 1985 Aug; 2(8449):229-33. PubMed ID: 2862415
[TBL] [Abstract][Full Text] [Related]
36. HLA-types in porphyria cutanea tarda.
Kuntz BM; Goerz G; Soneborg HH; Lissner R
Lancet; 1981 Jan; 1(8212):155. PubMed ID: 6109830
[No Abstract] [Full Text] [Related]
37. Denaturing gradient gel electrophoresis analysis of the hemochromatosis (HFE) gene: impact of HFE gene mutations on the manifestation of porphyria cutanea tarda.
Christiansen L; Bygum A; Thomsen K; Brandrup F; Hørder M; Petersen NE
Clin Chem; 1999 Nov; 45(11):2025-6. PubMed ID: 10545080
[No Abstract] [Full Text] [Related]
38. Generation of chemotactic activity in serum from patients with erythropoietic protoporphyria and porphyria cutanea tarda.
Lim HW; Perez HD; Poh-Fitzpatrick M; Goldstein IM; Gigli I
N Engl J Med; 1981 Jan; 304(4):212-6. PubMed ID: 7442746
[No Abstract] [Full Text] [Related]
39. High prevalence of the His63Asp HFE mutation in Italian patients with porphyria cutanea tarda.
Sampietro M; Piperno A; Lupica L; Arosio C; Vergani A; Corbetta N; Malosio I; Mattioli M; Fracanzani AL; Cappellini MD; Fiorelli G; Fargion S
Hepatology; 1998 Jan; 27(1):181-4. PubMed ID: 9425935
[TBL] [Abstract][Full Text] [Related]
40. Serum antibodies against porphyric hepatocytes in patients with porphyria cutanea tarda and liver disease.
Baravalle E; Prieto J
Gastroenterology; 1983 Jun; 84(6):1483-91. PubMed ID: 6840477
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
